DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Ausgabe 12 · Volume 84 · 2000 DOI: 10.1055/s-008-36104

Commentary

935
Brenner, Benjamin: Hereditary Deficiency of Vitamin K-dependent Coagulation Factors

Rapid Communication

937
Oldenburg, J.; von Brederlow, B.; Fregin, A.; Rost, S.; Wolz, W.; Eberl, W.; Eber, S.; Lenz, E.; Schwaab, R.; Brackmann, H. H.; Effenberger, W.; Harbrecht, U.; Schurgers, L. J.; Vermeer, C.; Müller, C. R.: Congenital Deficiency of Vitamin K Dependent Coagulation Factors in Two Families Presents as a Genetic Defect of the Vitamin K-Epoxide-Reductase-Complex

Review Article

942
Lundblad, Roger L.; Kingdon, Henry S.; Mann, Kenneth G.; White, Gilbert C.: Issues with the Assay of Factor VIII Activity in Plasma and Factor VIII Concentrates
949
The TERIMA Group of Investigators; Marrero-Miragaya, María Acelia: TERIMA-2: National Extension of Thrombolytic Treatment with Recombinant Streptokinase in Acute Myocardial Infarct in Cuba
955
Bolibar, Ignasi; von Eckardstein, Arnold; Assmann, Gerd; Thompson, Simon; The ECAT Angina Pectoris Study Group: Short-term Prognostic Value of Lipid Measurements in Patients with Angina pectoris
961
Høibraaten, Else; Qvigstad, Erik; Arnesen, Harald; Larsen, Stig; Wickstrøm, Egil; Sandset, Per Morten: Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy
968
de Valk-de Roo, Gerdien W.; Stehouwer, Coen D. A.; Emeis, Jef J.; Nicolaas-Merkus, Ans; Netelenbos, Coen: Unopposed Estrogen Increases Total Plasma Factor VII, but not Active Factor VII
973
Mac Gillavry, Melvin R.; Sanson, Bernd-Jan; Büller, Harry R.; Brandjes, Dees P. M.; the ANTELOPE-Study Group; on behalf of: Compression Ultrasonography of the Leg Veins in Patients with Clinically Suspected Pulmonary Embolism
977
Fischer, K.; van der Bom, J. G.; Mauser-Bunschoten, E. P.; Roosendaal, G.; Beek, F. J. A.; de Kleijn, P.; Grobbee, D. E.; van den Berg, H. M.: Endogenous Clotting Factor Activity and Long-term Outcome in Patients with Moderate Haemophilia
981
Koscielny, Jürgen K.; Latza, Reinhard; Mürsdorf, Stefan; Mrowietz, Christof; Kiesewetter, Holger; Wenzel, Ernst; Jung, Friedrich: Capillary Microscopic and Rheological Dimensions for the Diagnosis of von Willebrand Disease in Comparison to other Haemorrhagic Diatheses
989
Akhavan, Sepideh; Mannucci, Pier M.; Lak, Manijeh; Mancuso, Giacomo; Mazzucconi, Maria G.; Rocino, Angiola; Jenkins, P. Vincent; Perkins, Stephen J.: Identification and Three-dimensional Structural Analysis of Nine Novel Mutations in Patients with Prothrombin Deficiency
998
Nitu-Whalley, Ioana C.; Riddell, Anne; Lee, Christine A.; Pasi, K. John; Owens, Dale; Enayat, M. Said; Perkins, Stephen J.; Jenkins, P. Vincent: Identification of Type 2 von Willebrand Disease in Previously Diagnosed Type 1 Patients: a Reappraisal Using Phenotypes, Genotypes and Molecular Modelling
1005
van der Plas, R. Martijn; Gomes, Lucio; Marquart, J. Arnoud; Vink, Tom; Meijers, Joost C. M.; de Groot, Philip G.; Sixma, Jan J.; Huizinga, Eric G.: Binding of von Willebrand Factor to Collagen Type III: Role of Specific Amino Acids in the Collagen Binding Domain of vWF and Effects of Neighboring Domains
1012
Galli, Monica; Dlott, Jeffrey; Norbis, Francesca; Ruggeri, Luisa; Cler, Linda; Triplett, Douglas A.; Barbui, Tiziano: Lupus Anticoagulants and Thrombosis: Clinical Association of Different Coagulation and Immunologic Tests
1017
Gray, Elaine; Walker, A. Dawn; Mulloy, Barbara; Barrowcliffe, Trevor W.: A Collaborative Study to Establish the 5th International Standard for Unfractionated Heparin
1023
Ong, Kelly; Horsfall, Wendy; Conway, Edward M.; Schuh, Andre C.: Early Embryonic Expression of Murine Coagulation System Components
1031
Wilberding, Julie A.; Castellino, Francis J.: Characterization of the Murine Coagulation Factor X Promoter
1039
Wallin, Reidar; Cain, Dean; Hutson, Susan M.; Sane, David C.; Loeser, Richard: Modulation of the Binding of Matrix Gla Protein (MGP) to Bone Morphogenetic Protein-2 (BMP-2)
1045
Nieuwenhuys, Cécile M. A.; Feijge, Marion A. H.; Béguin, Suzette; Heemskerk, Johan W. M.: Monitoring Hypocoagulant Conditions in Rat Plasma: Factors Determining the Endogenous Thrombin Potential of Tissue Factor-Activated Plasma
1052
Mulloy, Barbara; Gray, Elaine; Barrowcliffe, Trevor W.: Characterization of Unfractionated Heparin: Comparison of Materials from the last 50 Years
1057
Citarella, Franca; te Velthuis, Henk; Helmer-Citterich, Manuela; Hack, C. Erik: Identification of a Putative Binding Site for Negatively Charged Surfaces in the Fibronectin Type II Domain of Human Factor XII
1066
Hoekema, Lico; Rosing, Jan; Tans, Guido: An Assay to Quantify the Two Plasma Isoforms of Factor V
1072
Kirchhofer, Daniel; Moran, Paul; Chiang, Nancy; Kim, Jin; Riederer, Markus A.; Eigenbrot, Charles; Kelley, Robert F.: Epitope Location on Tissue Factor Determines the Anticoagulant Potency of Monoclonal Anti-tissue Factor Antibodies
1082
Leng, Henry M. J.; Brouwers, Els; Knockaert, Isabelle; Declerck, Paul J.: Immunoassays for the Quantitation of Porcine PAI-1 Antigen and Activity in Biological Fluid Samples
1087
Rouhiainen, Ari; Imai, Shinji; Rauvala, Heikki; Parkkinen, Jaakko: Occurrence of Amphoterin (HMG1) as an Endogenous Protein of Human Platelets that Is Exported to the Cell Surface upon Platelet Activation
1095
Jennings, Lisa K.; Haga, Jason H.; Slack, Steven M.: Differential Expression of a Ligand Induced Binding Site (LIBS) by GPIIb-IIIa Ligand Recognition Peptides and Parenteral Antagonists
1103
Smyth, Susan S.; Tsakiris, Dimitrios A.; Scudder, Lesley E.; Coller, Barry S.: Structure and Function of Murine αIIbβ3 (GPIIb/IIIa): Studies Using Monoclonal Antibodies and β3-null Mice
1109
Altman, Raul; Scazziota, Alejandra; Rouvier, Jorge; Gonzalez, Claudio: Effect of Sodium Arachidonate on Thrombin Generation through Platelet Activation – Inhibitory Effect of Aspirin
1113
Roller, Regina E.; Janisch, Sandra; Kvas, Erich; Schnedl, Wolfgang J.; Binder, Bernd R.; Wojta, Johann; Korninger, Christian: Smooth Muscle Cell Migration Promoting Activity of Plasma Predicts Restenosis in Patients with Peripheral Arterial Occlusive Disease Undergoing Angioplasty

Letters to the Editor

1117
Alhenc-Gelas, Martine; Reny, Jean-Luc; Aubry, Marie-Laurence; Aiach, Martine; Emmerich, Joseph: The FXIII Val 34 Leu Mutation and the Risk of Venous Thrombosis
1120
Stief, Thomas W.: Functional Determination of Soluble Fibrin Polymers (SFP) in Plasma
1122
Depasse, F.; Gilbert, M.; Goret, V.; Rolland, N.; Samama, M. M.: Anti-Xa Monitoring: Inter-assay Variability
1122
Depasse, F.; Gilbert, M.; Goret, V.; Rolland, N.; Samama, M. M.: Anti-Xa Monitoring: Inter-assay Variability
1125
Oger, Emmanuel; Alhenc-Gelas, Martine; Plu-Bureau, Geneviève; Guize, Louis; Scarabin, Pierre-Yves: Plasma 17β Estradiol Is Inversely Correlated with Circulating Vascular Cell Adhesion Molecule
1126
Fuse, Ichiro; Ozawa, Tetsuo; Higuchi, Wataru; Aizawa, Yoshifusa: Antithrombin Niigata: A Novel Missense Mutation (Thrl94-lle) of the Antithrombin Gene Results in Type I Deficiency
1127
Federici, Augusto B.; Canciani, Maria Teresa; Forza, Ileana; Cozzi, Giovanna: Ristocetin Cofactor and Collagen Binding Activities Normalized to Antigen Levels for a Rapid Diagnosis of Type 2 von Willebrand Disease
1128
Schroder, V.; Kohler, H. P.: Effect of Factor XIII Val34Leu on α2-antiplasmin Incorporation into Fibrin
1131
Montefusco, Maria Claudia; Asselta, Rosanna; van Wijk, Richard; Duga, Stefano; Tenchini, Maria Luisa: Concerns about the Mutations Identified in a Case of Familial Coagulation Factor V Deficiency: Factor V Stanford
1132
Field, Susan L.; Chesterman, Colin N.; Hogg, Philip J.: Dependence on Prothrombin for Inhibition of Activated Protein C Activity by Lupus Antibodies

Letter to the Editor

1118
Margaglione, Maurizio; Bossone, Anna; Brancaccio, Vincenzo; Ciampa, Antonio; Di Minno, Giovanni: Factor XIII Val34Leu Polymorphism and Risk of Deep Vein Thrombosis
1123
Schwarzinger, Ile; Speiser, Wolfgang; Lubenow, Norbert; Greinacher, Andreas; Panzer, Simon: Heparin-Platelet Factor (PF) 4 Antibodies in Patients with Pseudothrombocytopenia: Coincidence or Association?
1130
Lüscher, E. F.: Rapid Shape Change – When, why and to what Purpose?
1134
Gerometta, M.; Rowbury, D.; Cooper, B.: Exclusion of Deep Venous Thrombosis with D-dimer Testing: